The Effect of Autologous Temporal Fascia Graft on Erectile Function and Psychometric Properties in Peyronie’s Disease Patients Temporal graft and Peyronie’s disease
Vol. 20 No. 01 (2023),
Purpose: The aim of this study is to evaluate the results of the surgical technique used by the authors on Peyronie's
disease (PD) patients who underwent surgical treatment with a temporalis fascia autograft.
Materials and Methods: Patients with normal erectile functions and > 60° penile curvature who underwent surgical
treatment with temporalis fascia autografts were included in this retrospective study. The patients were recruited
between January 2017 and May 2021. Preoperative assessment included the International Index of Erectile
Function erectile function (IIEF-EF) score, penile duplex and penile curvature angle measurement. Postoperative
self-reports, penile deformity, IIEF-EF scores and the Patient Global Impression of Improvement (PGI-I) questionnaire
were assessed every three months.
Results: Twenty-two patients with a mean age of 52.09 ± 6.61 years were included in the study, and no major complications developed in any case. Postoperative assessment revealed curvature relapse in seven patients (31.8%), although no intervention was performed on five patients with < 20° curvature. Six patients experienced a postoperative decrease in penile length and erectile function was completely preserved in 68.18%. The mean level of satisfaction with surgery measured using the visual analogue scale was 79.13 ± 21.23.
Conclusion: The temporalis fascia graft, thin and durable graft, is a highly successful therapeutic option in the
surgical treatment of PD patients and a good alternative in terms of its cosmetic and functional results.
- Peyronie’s disease
- temporalis fascia
- autologous graft
How to Cite
Chung E, Gillman M, Tuckey J, La Bianca S, Love C. A clinical pathway for the management of Peyronie's disease: integrating clinical guidelines from the International Society of Sexual Medicine, American Urological Association and European Urological Association. BJU Int. 2020;126(Suppl 1):12-7.
Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The Prevalence of Peyronie's Disease in the United States: A Population-Based Study. PLoS One. 2016;11(2):e0150157.
Kadioglu A, Dincer M, Salabas E, Culha MG, Akdere H, Cilesiz NC. A Population-Based Study of Peyronie's Disease in Turkey: Prevalence and Related Comorbidities. Sex Med. 2020;8:679–85.
Rice PG, Somani BK, Rees RW. Twenty Years of Plaque Incision and Grafting for Peyronie’s Disease: A Review of Literature. Sex Med. 2019;7:115e128.
Bilgutay AN, Pastuszak AW. Peyronie’s Disease: A Review of Etiology, Diagnosis, and Management. Curr Sex Health Rep. 2015;7:117–31.
Salonia A, Bettocchi C, Carvalho J, et al. European Association of Urology Guidelines on Sexual and Reproductive Health. https://uroweb.org/guideline/sexual-and-reproductive-health/#8. Access: 1 May 2021.
Bajic P, Siebert AL, Amarasekera CA, Miller CH, Levine LA. Comparing Outcomes of Grafts Used in Peyronie’s Disease Surgery: a Systematic Review. Curr Sex Health Rep. 2020;12:236–43.
Brannigan RE, Kim ED, Oyasu R, McVary KT. Comparison of tunica albuginea substitutes for the treatment of Peyronie’s disease. J Urol. 1998;159:1064–8.
Bella AJ, Lee JC, Grober ED, et al. 2018 Canadian Urological Association guideline for Peyronie’s disease and congenital penile curvature. Can Urol Assoc J. 2018;12:E197-209.
Gelbard MK, Hayden B. Expanding contractures of the tunica albuginea due to Peyronie’s disease with temporalis fascia free grafts. J Urol. 1991;145:772–6.
Rosenhammer B, Sayedahmed K, Fritsche HM, Burger M, Kübler H, Hatzichristodoulou G. Long-term outcome after grafting with small intestinal submucosa and collagen fleece in patients with Peyronie's disease: a matched pair analysis. Int J Impot Res. 2019;31(4):256-62.
Vickers AJ, Tin AL, Singh K, Dunn RL, Mulhall J. Updating the International Index of Erectile Function: Evaluation of a Large Clinical Data Set. J Sex Med. 2020;17(1):126-32.
Yıkılmaz TN, Öztürk E, Hamidi N, Selvi İ, Başar H, Peşkircioğlu L. Evaluation of sexual dysfunction prevalence in infertile men with non-obstructive azoospermia. Arch Ital Urol Androl. 2020;91(4):241-44.
Viktrup L, Hayes RP, Wang P, Shen W. Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. BMC Urol. 2012;12:30.
Kargi E, Yeşilli C, Hoşnuter M, Akduman B, Babuccu O, Mungan A. Relaxation incision and fascia lata grafting in the surgical correction of penile curvature in Peyronie's disease. Plast Reconstr Surg. 2004;113(1):254-9.
Garcia-Gomez B, Ralph D, Levine L, et al. Grafts for Peyronie's disease: a comprehensive review. Andrology. 2018;6(1):117-26.
Hatzichristodoulou G. Novel approaches and new grafting materials in Peyronie's disease reconstructive surgery. Int J Impot Res. 2020;32(1):37‐42.
Hatzichristodoulou G, Fiechtner S, Gschwend JE, Kübler H, Lahme S. Suture-free sealing of tunical defect with collagen fleece after partial plaque excision in Peyronie’s disease: long-term outcomes of the sealing technique. Eur Urol Suppl. 2017;16:e2152.
Salem E, Elkady EH, Sakr A, et al. Lingual mucosal graft in treatment of Peyronie disease. Urology. 2014;84:1374–7.
Fabiani A, Servi L, Fioretti F, et al. Buccal mucosa is a promising graft in Peyronie's disease surgery. Our experience and a brief literature review on autologous grafting materials. Arch Ital Urol Androl. 2016;88(2):115‐21.
Kayigil O, Ozcan MF, Cakici OU. The comparison of an acellular matrix graft with an autologous venous graft in the surgical treatment of Peyronie's disease. Andrologia. 2019;51(1):e13168.
Valente P, Gomes C, Tomada N. Small intestinal submucosa grafting for peyronie disease: outcomes and patient satisfaction. Urology. 2017;100:117–24.
Cosentino M, Kanashiro A, Vives A, et al. Surgical treatment of Peyronie’s disease with small intestinal submucosa graft patch. Int J Impot Res. 2016;28:106–9.
Chung E. Penile Reconstructive Surgery in Peyronie Disease: Challenges in Restoring Normal Penis Size, Shape, and Function. World J Mens Health. 2020;38(1):1-8.
Zucchi A, Silvani M, Pastore AL, et al. Corporoplasty using buccal mucosa graft in Peyronie disease: is it a first choice?. Urology. 2015;85(3):679-83.
- Abstract Viewed: 0 times
- 7376/pdf Downloaded: 0 times